Phosphate lowering agent
Showing 1 - 25 of >10,000
Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,
Completed
- Hyperphosphatemia
- +2 more
- Ferric Citrate 1 gram Oral Tablet
- Standard of care phosphate-lowering therapy
-
Anchorage, Alaska
- +12 more
Nov 3, 2022
Postoperative Pain Trial in Ankara (Calcium phosphate desensitizer)
Completed
- Postoperative Pain
- Calcium phosphate desensitizer
-
Ankara, TurkeyBaskent University
Dec 15, 2022
Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia Trial in Yongin (Evolocumab 140 MG/ML, Rosuvastatin 5mg, Ezetimibe 10mg)
Recruiting
- Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
- Evolocumab 140 MG/ML
- +2 more
-
Yongin, Gyeonggi-do, Korea, Republic ofYongcheol Kim
Jan 6, 2023
Kidney Failure, Chronic, Hyperphosphatemia Trial in Worldwide (Liberal phosphate target, Intensive phosphate target)
Recruiting
- Kidney Failure, Chronic
- Hyperphosphatemia
- Liberal phosphate target
- Intensive phosphate target
-
Camperdown, New South Wales, Australia
- +70 more
Dec 5, 2022
Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome Trial in Poltava (Pioglitazone 15 mg Tablet, Isosorbide
Completed
- Adverse Effect
- +2 more
- Pioglitazone 15 mg Tablet
- +5 more
-
Poltava, UkraineUkrainian Medical Stomatological Academy
Jan 9, 2022
Healthy, Chronic Kidney Disease Trial in Birmingham (Diet)
Completed
- Healthy
- Chronic Kidney Disease
- Diet
-
Birmingham, AlabamaUniversity of Alabama
Mar 10, 2021
Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor Trial in United States (drug, procedure, radiation)
Recruiting
- Malignant Rhabdoid Tumor
- Atypical Teratoid Rhabdoid Tumor
- alisertib
- +9 more
-
Los Angeles, California
- +10 more
Aug 1, 2022
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
Healthy Trial in Lund (Lumentin® 44 Powder for oral foam)
Completed
- Healthy
- Lumentin® 44 Powder for oral foam
-
Lund, Skåne, SwedenPeritusClinic
Mar 10, 2023
Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy Trial in Worldwide (SBR759, Sevelamer HCl)
Completed
- Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
- SBR759
- Sevelamer HCl
-
Chula Vista, California
- +65 more
Dec 11, 2020
Hyperglycemia, Renal Transplant Complication Primary Non-Function, Diabetes Trial (Semaglutide 14 MG [Rybelsus], Placebo)
Not yet recruiting
- Hyperglycemia
- +2 more
- Semaglutide 14 MG [Rybelsus]
- Placebo
- (no location specified)
Feb 1, 2023
Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)
Completed
- Chronic Kidney Disease Requiring Chronic Dialysis
- Hyperphosphatemia
-
Lauderdale Lakes, FloridaSouth Florida Research Institute
Sep 28, 2022
IBD Trial in Tanta (Mesalamine, Fenofibrate 160mg)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate 160mg
-
Tanta, EgyptTanta Unuversity
Mar 6, 2023
Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,
Not yet recruiting
- Acute Coronary Syndrome
- Non ST Segment Elevation Acute Coronary Syndrome
- Tafolecimab
- +2 more
- (no location specified)
Oct 20, 2023
Reversible Pulpitis Trial in Rohtak (Complete Pulpotomy using Mineral Trioxide Aggregate, Complete Pulpotomy using Simvastain
Unknown status
- Reversible Pulpitis
- Complete Pulpotomy using Mineral Trioxide Aggregate
- Complete Pulpotomy using Simvastain -alphatricalcium phosphate
-
Rohtak, Haryana, IndiaPGIDS
May 1, 2020
Kidney Stone Trial in Bern (Indapamide 2.5 MG, Hydrochlorothiazide 50Mg, Chlorthalidone 25mg)
Not yet recruiting
- Kidney Stone
- Indapamide 2.5 MG
- +2 more
-
Bern, SwitzerlandInselspital, Department of Nephrology and Hypertension
Oct 26, 2023
Hyperphosphatemia Trial in Kanoya (KHK7791)
Active, not recruiting
- Hyperphosphatemia
-
Kanoya, Kagoshima, JapanMedical Corporation Seijinkai Ikeda Hospital
Sep 7, 2021
Carious Lesion Trial in Islamabad (Adhesive resin restoration using Titania nanoparticle reinforced bonding agent, Adhesive
Enrolling by invitation
- Carious Lesion
- Adhesive resin restoration using Titania nanoparticle reinforced bonding agent
- Adhesive resin restoration without Titania nanoparticle incorporated bonding agen
-
Islamabad, PakistanSchool of Dentistry, Pakistan Institute of Medical Sciences
Feb 24, 2023
Chronic Kidney Diseases, Hyperphosphatemia Trial in Chengdu (AP-306, Sevelamer Carbonate)
Recruiting
- Chronic Kidney Diseases
- Hyperphosphatemia
- AP-306
- Sevelamer Carbonate
-
Chengdu, Sichuan, ChinaSichuan Provincial People's Hospital
Mar 9, 2023
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
-
Amman, Jordan
- +1 more
Nov 23, 2022
Dental Root Sensitivity Trial in Abha (desensitizing agents -10% Propolis)
Completed
- Dental Root Sensitivity
- desensitizing agents -10% Propolis
-
Abha, Aseer, Saudi ArabiaCollege of Dentistry King Khalid University
Oct 18, 2022
Lynch Syndrome Trial in Philadelphia (Atorvastatin 20mg, Atorvastatin 20mg AND Aspirin 325 mg)
Recruiting
- Lynch Syndrome
- Atorvastatin 20mg
- Atorvastatin 20mg AND Aspirin 325 mg
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 6, 2022
Physical Inactivity, Phosphate Overload, Visceral Obesity Trial (Sodium Phosphate, Sodium Chloride)
Not yet recruiting
- Physical Inactivity
- +2 more
- Sodium Phosphate
- Sodium Chloride
- (no location specified)
Aug 5, 2022
Type 2 Diabetes Trial in Seongnam (Sitagliptin, Dapagliflozin, Lobeglitazone)
Completed
- Type 2 Diabetes
- Sitagliptin
- +4 more
-
Seongnam, Gyeonggi, Korea, Republic ofSoo Lim
Jan 2, 2022